Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis.
Mutukula N, Man Z, Takahashi Y, Iniesta Martinez F, Morales M, Carreon-Guarnizo E, Hernandez Clares R, Garcia-Bernal D, Martinez Martinez L, Lajara J, Nuñez Delicado E, Meca Lallana JE, Izpisua Belmonte JC. Mutukula N, et al. Among authors: iniesta martinez f. Stem Cell Res. 2021 May;53:102319. doi: 10.1016/j.scr.2021.102319. Epub 2021 Apr 15. Stem Cell Res. 2021. PMID: 33894548 Free article.
Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules.
Fuentes-Rumí L, Hernández-Clares R, Carreón-Guarnizo E, Valero-López G, Iniesta-Martinez F, Cabrera-Maqueda JM, León-Hernández A, Zamarro-Parra J, Morales-Ortiz A, Meca-Lallana JE. Fuentes-Rumí L, et al. Among authors: iniesta martinez f. Mult Scler Relat Disord. 2020 Sep;44:102311. doi: 10.1016/j.msard.2020.102311. Epub 2020 Jun 20. Mult Scler Relat Disord. 2020. PMID: 32593958
Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test).
Meca-Lallana JE, Prieto-González JM, Jimenez-Veiga J, Carreón-Guarnizo E, Jiménez-Martín I, Hernández-Clares R, Sistiaga-Berrondo A, Carles-Dies R, García-Molina E, Cerdán-Sánchez M, Costa-Arpín E, Croitoru I, Castillo-Triviño T, Iniesta-Martinez F, García-Pérez E, Olascoaga-Urtaza J. Meca-Lallana JE, et al. Among authors: iniesta martinez f. Mult Scler Relat Disord. 2019 Feb;28:50-56. doi: 10.1016/j.msard.2018.12.003. Epub 2018 Dec 3. Mult Scler Relat Disord. 2019. PMID: 30553169
Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm.
Valero-López G, Carreón-Guarnizo E, Hernández-Clares R, Iniesta-Martínez F, Jiménez-Veiga J, Moreno-Docon A, Iborra-Bendicho MA, Aznar-Robles E, Hellín-Gil MF, Morales-Ortiz A, Meca-Lallana JE. Valero-López G, et al. Among authors: iniesta martinez f. Neurologia (Engl Ed). 2020 Jul-Aug;35(6):357-362. doi: 10.1016/j.nrl.2020.06.001. Epub 2020 Jun 8. Neurologia (Engl Ed). 2020. PMID: 32591152 Free PMC article. English, Spanish.
Treatment with natalizumab during pregnancy in multiple sclerosis: The experience of implementing a clinical practice protocol (NAP-30).
Valero-López G, Millán-Pascual J, Iniesta-Martínez F, Delgado-Marín JL, Jimenez-Veiga J, Tejero-Martín AB, León-Hernández A, Zamarro-Parra J, Morales-Ortiz A, Meca-Lallana JE. Valero-López G, et al. Among authors: iniesta martinez f. Mult Scler Relat Disord. 2022 Oct;66:104038. doi: 10.1016/j.msard.2022.104038. Epub 2022 Jul 7. Mult Scler Relat Disord. 2022. PMID: 35870370 Free article.
Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders.
Carreón Guarnizo E, Hernández Clares R, Castillo Triviño T, Meca Lallana V, Arocas Casañ V, Iniesta Martínez F, Olascoaga Urtaza J, Meca Lallana JE. Carreón Guarnizo E, et al. Among authors: iniesta martinez f. Neurologia (Engl Ed). 2022 Apr;37(3):178-183. doi: 10.1016/j.nrl.2018.12.013. Epub 2019 Mar 28. Neurologia (Engl Ed). 2022. PMID: 30928236 Free article. English, Spanish.
Erratum to "Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm" [Neurologia. 2020;35(6):357-362].
Valero-López G, Carreón-Guarnizo E, Hernández-Clares R, Iniesta-Martínez F, Jiménez-Veiga J, Moreno-Docon A, Iborra-Bendicho MA, Aznar-Robles E, Hellín-Gil MF, Morales-Ortiz A, Meca-Lallana JE. Valero-López G, et al. Among authors: iniesta martinez f. Neurologia (Engl Ed). 2020 Sep;35(7):541. doi: 10.1016/j.nrl.2020.07.011. Neurologia (Engl Ed). 2020. PMID: 32800282 Free PMC article. English, Spanish. No abstract available.
Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders.
Carreón Guarnizo E, Hernández Clares R, Castillo Triviño T, Meca Lallana V, Arocas Casañ V, Iniesta Martínez F, Olascoaga Urtaza J, Meca Lallana JE. Carreón Guarnizo E, et al. Among authors: iniesta martinez f. Neurologia (Engl Ed). 2022 Apr;37(3):178-183. doi: 10.1016/j.nrleng.2018.12.021. Epub 2021 Feb 26. Neurologia (Engl Ed). 2022. PMID: 35465911 Free article.
Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study.
Millán-Pascual J, Valero-López G, Iniesta-Martinez F, Hellin-Gil MF, Jimenez-Veiga J, López-Tovar IA, Morales-Ortiz A, Meca-Lallana JE. Millán-Pascual J, et al. Among authors: iniesta martinez f. Neurol Ther. 2024 Feb;13(1):153-164. doi: 10.1007/s40120-023-00572-8. Epub 2023 Dec 14. Neurol Ther. 2024. PMID: 38097868 Free PMC article.
11 results